G4R-29970-40517
3 vaccinations
8 coded responses
12 check-ins
8 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 956 / CA
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Survey response — day 14, dose 1MedDRA: Dizziness — Feeling: GoodFree text: Dizzy and ligjt headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — day 21, dose 1MedDRA: Dizziness, Fatigue, Pain — Feeling: FairFree text: Drizzy and light headed. Tired painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
-
2021-03-03
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-18
-
2021-03-24
Survey response — day 21, dose 2MedDRA: Arthralgia, Back pain, Muscular weakness, Neck pain, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Higher pian levels in my neck shoulders upper back snd arms. Weakness in armsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — day 28, dose 2MedDRA: Dyspnoea, Headache, Pain — Feeling: FairFree text: Higher levels of piam. Headaches short of breatheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — day 42, dose 2MedDRA: Fatigue, Headache, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rash, fatigue and worsening headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-30
Dose 3 — Pfizer-BioNTech
- 2021-06-04
-
2021-09-01
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Insomnia, Mobility decreased, Pain, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I am having a very bad flairup of my fibromyalgia. Spending more than half a day in bed with intense pain Not able to sleep from pain.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-03-05
Survey response — 12 months, dose 2MedDRA: Cough, Dyspnoea, Headache — Feeling: FairFree text: continued shortness of breath, severe headaches and presistant coughMedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
- 2022-04-01
-
2022-05-30
Survey response — 12 months, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: FairFree text: Fibromyalgia flare upMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-05-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 4 — day 14, dose 1
Symptoms: Dizzy and ligjt headed
Release 4 — day 21, dose 1
Symptoms: Drizzy and light headed. Tired pain
Release 6 — day 21, dose 2
Symptoms: Higher pian levels in my neck shoulders upper back snd arms. Weakness in arms
Release 6 — day 28, dose 2
Symptoms: Higher levels of piam. Headaches short of breathe
Release 7 — day 42, dose 2
Symptoms: Rash, fatigue and worsening headaches
Release 9 — 6 months, dose 2
Symptoms: I am having a very bad flairup of my fibromyalgia. Spending more than half a day in bed with intense pain Not able to sleep from pain.
Release 11 — 12 months, dose 2
Symptoms: continued shortness of breath, severe headaches and presistant cough
Release 11 — 12 months, dose 3
Symptoms: Fibromyalgia flare up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | · | ✓ |
| SD | Mobility decreased | ✓ | · | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release